OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Apr 28, 2026, 4:00 PM EDT
1.170
-0.040 (-3.31%)
After-hours: Apr 28, 2026, 5:23 PM EDT
OPKO Health Employees
OPKO Health had 2,275 employees as of December 31, 2025. The number of employees decreased by 722 or -24.09% compared to the previous year.
Employees
2,275
Change (1Y)
-722
Growth (1Y)
-24.09%
Revenue / Employee
$266,760
Profits / Employee
-$99,200
Market Cap
918.47M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,275 | -722 | -24.09% |
| Dec 31, 2024 | 2,997 | -933 | -23.74% |
| Dec 31, 2023 | 3,930 | -266 | -6.34% |
| Dec 31, 2022 | 4,196 | -1,571 | -27.24% |
| Dec 31, 2021 | 5,767 | 498 | 9.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| NeoGenomics | 2,500 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| GRAIL | 910 |
| Castle Biosciences | 883 |
| CareDx | 765 |
| Veracyte | 755 |
OPK News
- 1 hour ago - OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results - GlobeNewsWire
- 6 days ago - OPKO Health's ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas - GlobeNewsWire
- 7 days ago - OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 - GlobeNewsWire
- 2 months ago - OPKO Health to Participate in the Jefferies Biotech on the Beach Summit - GlobeNewsWire
- 2 months ago - OPKO Health Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 2 months ago - OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 - GlobeNewsWire
- 2 months ago - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism - GlobeNewsWire